Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva makes $40B offer for Mylan
Teva Pharmaceutical: Value at Last - WSJ
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva Poised to Face U.S. Charges in Drug Price-Fixing Probe - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
